Pfizer’s drug for inflammatory bowel disease has received EU approval

A drug to treat patients with an inflammatory bowel disease called ulcerative colitis has been approved by the European Commission. The approval of Velsipity followed support from a panel of experts at the European Medicines Agency in December.

Share This Post:

POPULAR POSTS
FOLLOW US
Like Us On Facebook
Follow Us On Twitter
Subscribe To Our Channel
TikTok
LIVE STREAM